Roivant Sciences Ltd. (ROIV) Misses Q3 EPS by 5c, Revenues Beat

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q3 non-GAAP EPS of ($0.42), $0.05 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $17.05 million versus the consensus estimate of $14.11 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
• Indosat Tbk PT (ISAT:IJ) (PTITF) PT Raised to IDR35.10 at JPMorgan